ZygoFix completed a $2 million round. Funds will support further clinical studies, enhancements to the company’s implant and tools, and regulatory clearance.
ZygoFix’s zLOCK™ is a miniature screwless implant that provides spinal stability and fusion. zLOCK replaces complex screw stabilization, and patented bendable features enable adjustment to specific joints’ shapes during insertion.
This case opens the Israeli clinical study site, following the ongoing study in Hungary which began in 2018. The study in Hungary demonstrated meaningful and sustained reduction in pain and increase in quality of life for patients, all with a minimally invasive, simple and short procedure.
ZygoFix CEO Ofer Levy said, “We are very satisfied with this first case in Israel as zLOCK adds a new treatment option to the surgeon’s toolbox. Its unique ability to perform internal facet fixation with a minimally invasive procedure enables us to treat pathologies in a simple manner, that were too complex and invasive to treat otherwise.”